share_log

4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

4：持股變動聲明-董事 YALE PHYLLIS R
美股sec公告 ·  07/02 17:32
Moomoo AI 已提取核心訊息
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has been involved in a transaction with the company's stock on June 30, 2024. The specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and there is no information provided about the number of shares held after the action.
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb Co. [BMY], has been involved in a transaction with the company's stock on June 30, 2024. The specific details regarding the nature of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the announcement. The relationship of Yale to the issuer was not specified, and there is no information provided about the number of shares held after the action.
Bristol-Myers Squibb Co.（BMY）的報告人Phyllis R. Yale於2024年6月30日參與了該公司股票的交易。關於交易性質的具體細節，包括股票數量、交易價格和總價值，在公告中未予披露。Yale與發行人的關係未被特別說明，對行動後持有的股份數量也沒有提供任何信息。
Bristol-Myers Squibb Co.（BMY）的報告人Phyllis R. Yale於2024年6月30日參與了該公司股票的交易。關於交易性質的具體細節，包括股票數量、交易價格和總價值，在公告中未予披露。Yale與發行人的關係未被特別說明，對行動後持有的股份數量也沒有提供任何信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息